0001209191-19-046444.txt : 20190819 0001209191-19-046444.hdr.sgml : 20190819 20190819061224 ACCESSION NUMBER: 0001209191-19-046444 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190815 FILED AS OF DATE: 20190819 DATE AS OF CHANGE: 20190819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cassella James V CENTRAL INDEX KEY: 0001353528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36310 FILM NUMBER: 191034793 MAIL ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001367920 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-0045 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060628 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-15 0 0001367920 CONCERT PHARMACEUTICALS, INC. CNCE 0001353528 Cassella James V C/O CONCERT PHARMACEUTICALS, INC. 65 HAYDEN AVENUE, SUITE 3000N LEXINGTON MA 02421 0 1 0 0 Chief Development Officer Common Stock 2019-08-15 4 A 0 31100 A 52265 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer. 35% of the RSUs granted to Mr. Cassella will vest on August 15, 2020, and the remaining 65% of the RSUs will vest on August 15, 2021. The number above represents the maximum number of shares that may be delivered pursuant to the award. Not applicable. /s/ Nancy Stuart as attorney-in-fact for James V. Cassella 2019-08-19